Results 201 to 210 of about 18,513 (261)

An unusual pancreas divisum intraductal papillary mucinous neoplasm diagnosed by pancreatoscopy-assisted endoscopic ultrasonography rendezvous procedure. [PDF]

Endoscopy
Agudo Castillo B, de la Iglesia D, Fernández-Zarza CE, Maderuelo González E, Cabrero Cabrero AI, Aguirre-Camino P, González-Haba Ruiz M.   +6 more
europepmc   +1 more source

Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma. [PDF]

Ann Surg Oncol
Fogliati A, Zironda A, Fiorentini G, Adjei S, Amro A, Starlinger PP, Grotz TE, Warner SG, Smoot RL, Thiels CA, Kendrick ML, Cleary SP, Truty MJ.   +12 more
europepmc   +1 more source

Optimal Surveillance Interval of Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas.

JAMA Surg
Han Y, Kwon W, Lee M, Jung HS, Yun WG, Cho YJ, Chae YS, Fernández-Del Castillo C, Marchegiani G, Salvia R, Goh BKP, Lee WJ, Jang JY.   +12 more
europepmc   +1 more source

Lymphocyte-to-Monocyte Ratio Predicts Survival for Intraductal Papillary Mucinous Neoplasm with Associated Invasive Carcinoma of the Pancreas: Results from a High-Volume Center.

Dig Surg
Cui M, Hu Y, Zheng B, Chen T, Dai M, Guo J, Zhang T, Yu J, Liao Q, Zhao Y.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Number of Worrisome Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasm.

Journal of the American College of Surgeons, 2022
BACKGROUND The 2017 revised International Association of Pancreatology guidelines for management of intraductal papillary mucinous neoplasm (IPMN) describe worrisome features (WF) and high-risk stigmata (HRS), recommending resection in the latter and ...
P. Zelga, Y. Hernandez-Barco, M. Qadan, C. Ferrone, A. Kambadakone, Nora Horick, A. Jah, A. Warshaw, K. Lillemoe, A. Balakrishnan, C. F. Fernandez-Del Castillo   +10 more
semanticscholar   +1 more source

Pathology of intraductal papillary mucinous neoplasms

Langenbeck's Archives of Surgery, 2021
Intraductal papillary mucinous neoplasms (IPMNs) represent a unique opportunity to treat and prevent a curable neoplasm before it has the chance to progress to incurable cancer. This prospect, however, has to be balanced with the real risk of over treating patients with lesions that would, in fact, never progress during the life of the patient.Informed
Naziheh Assarzadegan, Elizabeth Thompson, Kevan Salimian, Matthias M. Gaida, Lodewijk A.A. Brosens, Laura Wood, Syed Z. Ali, Ralph H. Hruban   +7 more
openaire   +4 more sources

Histopathological evaluation of minor salivary gland papillary–cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm

Histopathology, 2020
Minor salivary gland tumours showing a predominant papillary–cystic structure are rare, and constitute a mixture of various types of neoplasm; thus, the histopathological assessment of these tumours poses a significant diagnostic challenge.
Masato Nakaguro, M. Urano, I. Ogawa, H. Hirai, Yoshinari Yamamoto, H. Yamaguchi, Maki Tanigawa, J. Matsubayashi, H. Hirano, J. Shibahara, Y. Tada, T. Tsuzuki, Y. Okada, Yuichiro Sato, K. Ikeda, Aoi Sukeda, Y. Honda, Y. Mikami, T. Nagao   +18 more
semanticscholar   +1 more source

Intraductal Papillary Mucinous Neoplasm

Ultrasound Quarterly, 2012
Intraductal papillary mucinous neoplasm (IPMN) is a grossly visible (≥1 cm), mucin-producing neoplasm that arises in the main pancreatic duct and/or its branches. Patients with intraductal papillary mucinous neoplasm can present with symptoms caused by obstruction of the pancreatic duct system, or they can be asymptomatic. There are 3 clinical subtypes
Scott Schiffman, Susan L. Voci, Joseph Reis   +2 more
openaire   +6 more sources

Natural history and optimal treatment strategy of intraductal papillary mucinous neoplasm of the pancreas: Analysis using a nomogram and Markov decision model

Journal of hepato-biliary-pancreatic sciences, 2020
With the increase in detection of intraductal papillary mucinous neoplasms (IPMN), a tailored approach is needed. This study was aimed at exploring the natural history of IPMN and suggest optimal treatment based on malignancy risk using a nomogram and ...
Youngmin Han, Jin‐Young Jang, M. Y. Oh, H. Kim, Y. Byun, J. Kang, S. H. Kim, K. Lee, Hongbeom Kim, W. Kwon   +9 more
semanticscholar   +1 more source